LifeVantage (NASDAQ:LFVN) Releases FY 2025 Earnings Guidance

LifeVantage (NASDAQ:LFVN - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.700-0.800 for the period, compared to the consensus EPS estimate of 0.720. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $204.8 million.

LifeVantage Trading Down 3.8 %

Shares of NASDAQ LFVN traded down $0.51 during midday trading on Tuesday, reaching $12.98. The company had a trading volume of 172,827 shares, compared to its average volume of 59,519. LifeVantage has a 1 year low of $4.20 and a 1 year high of $14.71. The business's 50-day simple moving average is $10.68 and its 200 day simple moving average is $8.27. The stock has a market cap of $164.86 million, a P/E ratio of 46.14 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by ($0.07). The firm had revenue of $48.93 million during the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were issued a $0.04 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.16 annualized dividend and a dividend yield of 1.23%. LifeVantage's dividend payout ratio (DPR) is presently 57.14%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.